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CASE REPORT
Intestinal tuberculosis masquerading 
as difficult to treat Crohn disease: a case report
Madunil A. Niriella1*, S. Kuleesha Kodisinghe2, Arjuna P. De Silva1, Janaki Hewavisenthi1 
and Hithanadura J. de Silva1
Abstract 
Background: Crohn disease has low prevalence in Sri Lanka while compared to the West, while intestinal tubercu-
losis is common in the region. Since clinical, endoscopic and investigation features of Crohn disease overlap with 
intestinal tuberculosis, differentiating these two conditions becomes a dilemma for the clinician in the intestinal 
tuberculosis endemic setting.
Case summary: An 18-year old Sri Lankan Muslim female presented with chronic abdominal pain and weight loss. 
Colonoscopy revealed an ulcerated ileocaecal valve and a terminal ileal stricture. Biopsy confirmed Crohn disease with 
no supportive features to suggest intestinal tuberculosis. Despite treatment with adequate immunosuppression she 
failed to improve and underwent a limited right hemicolectomy and terminal ileal resection. Histology confirmed 
intestinal tuberculosis and she made full recover with 6 months of anti-tuberculosis treatment.
Conclusion: This case illustrates the importance of reviewing the diagnosis to include intestinal tuberculosis in an 
endemic setting, when already diagnosed Crohn disease is treatment refractory.
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Background
The prevalence of Crohn disease (CD) is low in Sri Lanka 
compared to the West. However, Crohn disease is increas-
ingly diagnosed in recent years [1]. Intestinal tuberculosis 
(ITB) is common in the South Asian region, but the exact 
prevalence is not reported from Sri Lanka. There is over-
lap of clinical, endoscopic and investigation features of CD 
and ITB. Therefore, differentiating these two conditions is a 
challenge for the clinician, especially among patients unre-
sponsive to initial treatment (Table 1). Furthermore, treat-
ment as for CD in the setting of missed ITB, especially with 
immunosuppresses and biologics, can be life threatening.
Case presentation
An 18  year old Sri Lankan Muslim female, presented 
with a 9  month history of colicky right iliac fossa pain 
and a 5  kg weight loss. She did not have diarrhoea, 
extra-intestinal manifestations of CD, and contact or past 
history of tuberculosis (TB). Clinical examination was 
normal.
Colonoscopy revealed an ulcerated ileocaecal valve and 
a terminal ileal stricture, while the colon itself was mac-
roscopically normal. Biopsy of these lesions was reported 
as suggestive of CD. TB polymerase chain reaction (PCR) 
performed on the specimen was negative. Contrast-
enhanced CT abdomen showed a segment of terminal 
ileum with concentric wall thickening. Mantoux test and 
Quantiferon gold test for TB were negative and chest 
X-ray was normal.
She was started on treatment for CD with a short 
course of oral steroids followed by azathioprine. How-
ever, she failed to tolerate azathioprine and subsequently 
6-mercaptopurine (6-MP), and therefore was started 
on intravenous infliximab. Despite 3 dose of inflixi-
mab she failed to respond, and a follow up colonoscopy 
showed persistence of the ileal stricture. Therefore she 
was referred for surgical resection of the involved ileal 
segment. During the laparotomy, multiple terminal ileal 
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and cecal strictures were noted and unexpectedly, mul-
tiple omental and peritoneal deposits were also seen. A 
limited right hemicolectomy including resection of the 
involved terminal ileum was performed.
Histology of the resected specimen showed multiple 
coalescent caseating granulomata involving full thick-
ness of the bowel wall and extending into the mesentery 
and pericolic fat, suggesting a diagnosis of ITB (Figs.  1, 
2). No evidence of dissemination beyond the intestine 
was found. She was started on anti-TB treatment (ATT), 
and 2  months later was free of abdominal pain and has 
regained 3 kg of weight. Three months after commencing 
ATT a repeat colonoscopy was performed. There were no 
macroscopic or microscopic changes in the neo-terminal 
ileum or residual colon. She completed 6 months of ATT 
and made a full recovery.
Discussion
The possibilities here are that the patient had ITB from 
the onset which was misdiagnosed as CD, or that the 
patient contracted ITB during immunosuppression 
with infliximab. There are numerous case reports in the 
literature where ITB was misdiagnosed as CD. There 
are also many reports of patients on infliximab develop-
ing TB, but none of these patients had TB isolated to the 
intestine. The most likely explanation in this patient is 
that of ITB misdiagnosed as CD. This is given the pos-
sibility of false negative skin test and TB PCR at initial 
evaluation, poor response to successive immunosuppres-
sion therapy, further worsening of bowel symptoms with 
infliximab therapy needing surgery and the complete res-
olution of clinical and endoscopic features with a course 
of ATT.
Histology is one of the most definitive methods of dif-
ferentiation of CD from ITB. Features described to be 
only found in ITB are caseating granulomata and conflu-
ent granulomata. Large numbers of granulomata (≥10 
per biopsy site), large granulomata (≥0.05  mm), ulcers 
lined by epithelioid histiocytes and disproportionate 
Table 1 Clinical, endoscopic and  radiological features 
which aid in differentiation of Crohn disease from intesti-
nal tuberculosis [2, 3]
Crohn disease Intestinal tuberculosis
Clinical
Prolonged remitting and relapsing  
course
Continuous disease of short 
duration






Longitudinal ulcers Transverse ulcers
Aphthous ulcers Ulcer scars
Cobblestone-like mucosa Patulous ileocaecal valve
Isolated terminal ileal involvement  
with relative caecal sparing
Anorectal lesions
Contrast enhanced CT
Multiple levels of involvement Involvement of less than four 
segments
Symmetric and concentric bowel  
wall thickening
Asymmetric bowel wall 
thickening
Mural stratification (target sign) Large necrotic mesenteric 
lymph nodes
Increased mesenteric vascular  
stranding (comb sign)
Fibrofatty proliferation in the  
mesentery (pathognomonic)
Fig. 1 Confluent granulomata within the muscularis propria with 
ulceration of the overlying colonic mucosa. H & E ×40
Fig. 2 Confluent granulomata with central caseation H & E ×100
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submucosal inflammation are other features suggested 
to support ITB. Acid-fast bacilli in biopsy specimens, 
although very specific, are not frequently encountered 
[2].
Polymerase chain reaction of biopsy specimens for 
mycobacterial DNA is rapid and reliable but still has false 
positives and negatives. There has been suggestion that 
faecal PCR is more sensitive than tissue PCR, but this 
needs to be investigated further [2]. Culture for M. tuber-
culosis from biopsy although definitive, is low in sensitiv-
ity (50 %) [2]. Specimens for TB culture was not taken at 
colonoscopy from this patient.
Although positivity of a tuberculin skin test (TST) and 
interferon gamma-release assay (IGRA) is supportive of 
ITB, in areas with a high prevalence of TB this may be 
an incidental positivity due to past TB exposure or in the 
case of TST also non-tuberculous mycobacteria or BCG 
vaccination. Furthermore, the use of corticosteroids and 
immunosuppressive drugs in a patient with IBD may 
limit the diagnostic utility of both these tests [2].
When all else fail, clinicians have a tendency to treat 
for ITB and monitor the response. This approach is safe 
given the potential for life threatening flare up of ITB, if 
treated as for CD in the setting of missed ITB, especially 
with immunosuppressive agents and biologics. Clini-
cal studies which have assessed this approach have sug-
gested that a short term (2–3 month) anti-TB treatment 
trial followed by re-endoscopy to look for healing may be 
valuable in the differential diagnosis of difficult cases [4]. 
Fortunately for this patient despite use of steroid, azathi-
oprine, 6-MP and infliximab, there was no life threaten-
ing systemic flare up of tuberculosis.
Conclusion
This case illustrates the importance of reconsidering 
ITB in an endemic stetting, in a patient with ‘diagnosed’ 
CD and ITB excluded at onset, but who fails to respond 
or becomes worse with immunosuppressive therapy. 
The reason for this may be in most instances the ini-
tial misdiagnosis of CD and missed ITB, or less likely 
the development of ITB in a patient with CD while on 
immunosuppression.
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